Improving the lives of our patients.
We work tirelessly to create life changing treatments that help our patients live better and fuller lives.
Learn More
Research & Development
We invest in innovative research and development through our own development or partnerships to best address the unmet needs of patients
Learn More
About Us
We are a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.
Learn More
— Research & Development
Oncology Pipeline
We continue to build our treatment portfolio with a current focus on oncology within the United States.
Learn More— Join Our Team
See a Future at Servier?
Learn more about working at Servier and search our current job openings to see if there is a career opportunity for you.
Learn More
Latest News
We are pleased to announce data from our global Phase 3 AGILE study in patients with previously untreated IDH1-mutated AML.
Learn More
As #ASH21 comes to an end, we’re grateful for the opportunity to share our latest findings with the #hematology community.
Learn More
Phase 3 Data Demonstrate TIBSOVO® in Combination with Azacitidine Significantly Improves Event-Free Survival & Overall Survival in Patients with Previously Untreated IDH1-mutated AML
Learn MoreAdobe Stock©Mat Hayward | Adobe Stock©REDPIXEL | Adobe Stock©Gorodenkoff | Adobe Stock©Monkey Business